ICU Medical, Inc Q3 2025 Conference Call Presentation November 6, 2025 1 In $Millions Warming Anesthesia & Resp Pain Kits Critical Care IV Solutions 1 Infusion Therapy Oncology Vascular Access Consumables Infusion Systems Vital Care Ambulatory Syringe LVP Infusion Tracheostomy 1 Revenue from IV Solutions is included in ICU Medical's consolidated revenue for all periods prior to the joint venture formation effective May 1, 2025 and excluded for all periods thereafter. | | | 2024 | 2024 | 2024 | 2024 | 2024 | ...